BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16982748)

  • 21. Effect of extracellular calcium on regucalcin expression and cell viability in neoplastic and non-neoplastic human prostate cells.
    Vaz CV; Rodrigues DB; Socorro S; Maia CJ
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2621-8. PubMed ID: 26171977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of the calcium sensing receptor and the Phosphoinositide 3-kinase/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells.
    Boudot C; Saidak Z; Boulanouar AK; Petit L; Gouilleux F; Massy Z; Brazier M; Mentaverri R; Kamel S
    Bone; 2010 May; 46(5):1416-23. PubMed ID: 20149906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
    Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
    Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
    Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
    Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor.
    Lin KI; Chattopadhyay N; Bai M; Alvarez R; Dang CV; Baraban JM; Brown EM; Ratan RR
    Biochem Biophys Res Commun; 1998 Aug; 249(2):325-31. PubMed ID: 9712695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal factors involved in prostate carcinoma metastasis to bone.
    Cooper CR; Chay CH; Gendernalik JD; Lee HL; Bhatia J; Taichman RS; McCauley LK; Keller ET; Pienta KJ
    Cancer; 2003 Feb; 97(3 Suppl):739-47. PubMed ID: 12548571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maspin reduces prostate cancer metastasis to bone.
    Hall DC; Johnson-Pais TL; Grubbs B; Bernal R; Leach RJ; Padalecki SS
    Urol Oncol; 2008; 26(6):652-8. PubMed ID: 18367129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
    Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
    Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
    Hall CL; Dai J; van Golen KL; Keller ET; Long MW
    Cancer Res; 2006 Sep; 66(17):8648-54. PubMed ID: 16951179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
    Jan CR; Chao YY
    Cell Signal; 2004 Aug; 16(8):959-65. PubMed ID: 15157675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
    Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
    Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
    Kumar B; Koul S; Khandrika L; Meacham RB; Koul HK
    Cancer Res; 2008 Mar; 68(6):1777-85. PubMed ID: 18339858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The extracellular calcium sensing receptor is expressed in mouse mesangial cells and modulates cell proliferation.
    Kwak JO; Kwak J; Kim HW; Oh KJ; Kim YT; Jung SM; Cha SH
    Exp Mol Med; 2005 Oct; 37(5):457-65. PubMed ID: 16264270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.
    Lee HL; Pienta KJ; Kim WJ; Cooper CR
    Int J Oncol; 2003 Apr; 22(4):921-6. PubMed ID: 12632088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of LOX-1 in monocyte adhesion-triggered redox, Akt/eNOS and Ca2+ signaling pathways in endothelial cells.
    Sakamoto N; Ishibashi T; Sugimoto K; Sawamura T; Sakamoto T; Inoue N; Saitoh S; Kamioka M; Uekita H; Ohkawara H; Suzuki K; Teramoto T; Maruyama Y; Takeishi Y
    J Cell Physiol; 2009 Sep; 220(3):706-15. PubMed ID: 19452449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression.
    Vijayvargia R; May MS; Fondell JD
    Cancer Res; 2007 May; 67(9):4034-41. PubMed ID: 17483314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
    Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.